Elevated inary excretion of 4-aminoimidazole-5-carboxamide in patients after intravenous injection of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide.
D000328:Adult; D000970:Antineoplastic Agents / Q000378:metabolism* / Q000652:urine; D002855:Chromatography, Thin Layer; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000378:metabolism*; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D008875:Middle Aged; D013053:Spectrophotometry
D000970:Antineoplastic Agents; D007093:Imidazoles